Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Jacob Funds capitalized on Q4 market volatility and tech cooling by selectively adding high-conviction growth names like Snowflake in cloud/AI infrastructure, alongside cutting-edge biotech innovators Cabaletta Bio and Prime Medicine.
Full Quick Take
Jacob Funds capitalized on Q4 market volatility and tech cooling by selectively adding high-conviction growth names like Snowflake in cloud/AI infrastructure, alongside cutting-edge biotech innovators Cabaletta Bio and Prime Medicine.
Titan Wealth capitalized on strong Q3 performance, delivering 11% in their Global Blue Chip strategy via robust AI thematic positioning, while incrementally shifting toward a 'barbell' allocation to manage US indexing concentration risks.
Full Quick Take
Titan Wealth capitalized on strong Q3 performance, delivering 11% in their Global Blue Chip strategy via robust AI thematic positioning, while incrementally shifting toward a 'barbell' allocation to manage US indexing concentration risks.
Alger Mid Cap Focus Fund outperformed its benchmark in Q3 2025, powered by strong performances in AI networking, fintech, and clean energy holdings, while maintaining high conviction in secular growth themes.
Full Quick Take
Alger Mid Cap Focus Fund outperformed its benchmark in Q3 2025, powered by strong performances in AI networking, fintech, and clean energy holdings, while maintaining high conviction in secular growth themes.
